Patents by Inventor John Srouji

John Srouji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR DELIVERY OF PLASMODIUM CSP ANTIGENS AND RELATED METHODS
    Publication number: 20260151470
    Abstract: The present disclosure provides compositions (e.g., pharmaceutical compositions) for delivery of malarial protein antigens and related technologies (e.g., components thereof and/or methods relating thereto). Among other things, the present disclosure provides polyribonucleotides encoding malarial protein antigens.
    Type: Application
    Filed: September 22, 2023
    Publication date: June 4, 2026
    Inventors: Ugur Sahin, Asaf Poran, Daniel Abram Rothenberg, Stephanie Erbar, Annette Vogel, Patricia dos Santos Meireles, John Srouji, Anja Dokic, Thorsten Klamp, Charles Jennison
  • METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CHARACTERIZATION OF CD4+ T CELLS
    Publication number: 20260031189
    Abstract: Methods for preparing a personalized cancer vaccine and a method to train a machine learning HLA-peptide presentation prediction model. Further wherein, a method of making a HLA class II tetramer or multimer comprising an epitope, the method comprising contacting a purified soluble HLA-DM loaded with a peptide epitope with a HLA class II tetramer or multimer, thereby forming a HLA class II tetramer or multimer loaded with the peptide epitope, is disclosed.
    Type: Application
    Filed: May 18, 2023
    Publication date: January 29, 2026
    Inventors: John Srouji, Rohit Vyasamneni, Dominik Barthelme
  • RNA COMPOSITIONS FOR DELIVERY OF MONKEYPOX ANTIGENS AND RELATED METHODS
    Publication number: 20250319177
    Abstract: The present disclosure provides pharmaceutical compositions for delivery of monkeypox antigens (e.g., a monkeypox vaccine) and related technologies (e.g., components thereof and/or methods relating thereto). For example, the present disclosure provides polyribonucleotides encoding one or more monkeypox antigens or fragments thereof.
    Type: Application
    Filed: May 25, 2023
    Publication date: October 16, 2025
    Inventors: Asaf Poran, Adam Zuiani, Charles Lefco Dulberger, Gavin Palowitch, John Srouji, Huitian Diao, Daniel Abram Rothenberg, Ugur Sahin, Nilushi S. De Silva, Anja Dokic, Ricardo Sanchez Velazquez, Katja Margit Schlatterer, Lynda Maria Stuart, Alexandra Walls
  • CORONAVIRUS VACCINES AND METHODS OF USE
    Publication number: 20230141371
    Abstract: Compositions and methods for the prevention and/or treatment of a viral infection, in particular of the Coronaviridae family.
    Type: Application
    Filed: March 19, 2021
    Publication date: May 11, 2023
    Inventors: Richard B. Gaynor, Lakshmi Srinivasan, Asaf Poran, Dewi Harjanto, Christina Kuksin, Daniel Abram Rothenberg, John Srouji
  • CORONAVIRUS VACCINES AND METHODS OF USE
    Publication number: 20230083931
    Abstract: Compositions and methods for the prevention and/or treatment of a viral infection, in particular of the Coronaviridae family.
    Type: Application
    Filed: September 22, 2021
    Publication date: March 16, 2023
    Inventors: Richard B. Gaynor, Lakshmi Srinivasan, Asaf Poran, Dewi Harjanto, Christina Kuksin, Daniel Abram Rothenberg, John Srouji, Stefanie Krumm, Kaushik Thanki